or Try an Advanced Search...

    Technical Analysis for ATXS - Astria Therapeutics, Inc.

    Grade Last Price % Change Price Change
    D 9.25 1.65% 0.15
    ATXS closed up 1.65 percent on Monday, July 1, 2024, on 53 percent of normal volume. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline. It ran into resistance at its 50 day moving average.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Flat Up
    Historical ATXS trend table...
    Date Alert Name Type % Chg
    50 DMA Resistance Bearish 0.00%
    20 DMA Support Bullish 0.00%
    Crossed Above 200 DMA Bullish 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    50 DMA Resistance Bearish 1.65%
    Fell Below 200 DMA Bearish 1.65%
    20 DMA Support Bullish 1.65%
    Bollinger Band Squeeze Range Contraction 1.65%
    Inside Day Range Contraction 1.65%
    50 DMA Resistance Bearish 0.33%
    Older End-of-Day Signals for ATXS ...

       Recent Intraday Alerts

    Alert Time
    Rose Above 50 DMA about 10 hours ago
    20 DMA Support about 10 hours ago
    10 DMA Support about 10 hours ago
    200 DMA Support about 10 hours ago
    Rose Above Previous Day's High about 10 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    ATXS Chart by TradingView
    Basic chart:

    Profile

    Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Clinical Medicine Life Sciences Immunology Monoclonal Antibody Antibody Angioedema Hereditary Angioedema Kallikrein Complement Deficiency

    Is ATXS a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 24 Astria Therapeutics: A Cash-Rich Entrant In An Increasingly Crowded Field
    Jun 4 Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    May 30 Astria Therapeutics to Present at Upcoming Jefferies Healthcare Conference
    May 24 Astria Therapeutics to Present at Upcoming Eastern Allergy Conference
    May 23 Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Congress
    May 11 We're Not Very Worried About Astria Therapeutics' (NASDAQ:ATXS) Cash Burn Rate
    May 10 Astria TherapeuticS GAAP EPS of -$0.38 misses by $0.02
    May 9 Astria Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update
    May 8 Astria Therapeutics to Present at Upcoming Society for Investigative Dermatology Annual Meeting
    Apr 9 Astria Therapeutics Appoints Sunil Agarwal to Its Board of Directors
    See more ATXS news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 16.9
    52 Week Low 4.26
    Average Volume 620,911
    200-Day Moving Average 9.13
    50-Day Moving Average 9.28
    20-Day Moving Average 9.08
    10-Day Moving Average 9.08
    Average True Range 0.42
    RSI (14) 50.50
    ADX 12.74
    +DI 22.51
    -DI 15.52
    Chandelier Exit (Long, 3 ATRs) 8.43
    Chandelier Exit (Short, 3 ATRs) 9.89
    Upper Bollinger Bands 9.40
    Lower Bollinger Band 8.76
    Percent B (%b) 0.76
    BandWidth 7.08
    MACD Line -0.09
    MACD Signal Line -0.14
    MACD Histogram 0.0565
    Fundamentals Value
    Market Cap 505.66 Million
    Num Shares 54.7 Million
    EPS -2.12
    Price-to-Earnings (P/E) Ratio -4.36
    Price-to-Sales 0.00
    Price-to-Book 9.36
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 9.73
    Resistance 3 (R3) 9.73 9.56 9.65
    Resistance 2 (R2) 9.56 9.44 9.57 9.62
    Resistance 1 (R1) 9.41 9.37 9.49 9.41 9.60
    Pivot Point 9.24 9.24 9.28 9.25 9.24
    Support 1 (S1) 9.09 9.12 9.17 9.09 8.90
    Support 2 (S2) 8.92 9.05 8.93 8.88
    Support 3 (S3) 8.77 8.92 8.85
    Support 4 (S4) 8.77